This symposium titled “Gadolinium Retention: Where Do We Stand?” explores new studies and recently published clinical data on the differentiating characteristics of GBCAs for MR imaging and the glymphatic system & blood-CSF barrier. It will also review the impact of this data on neuroimaging in pediatric and other special populations. The purpose of this symposium is to provide physicians and other health care professionals with current clinical data to make informed decisions in their clinical settings.
GBCA Tolerability: Adverse Events and Differentiating Characteristics – CE
About this product
Category: On-Line Enduring CE